• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Director Raines William F Iii was granted 1,572 shares, increasing direct ownership by 15% to 12,104 units (SEC Form 4)

    5/20/25 5:23:18 PM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary
    Get the next $YCBD alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Raines William F III

    (Last) (First) (Middle)
    2101 WESTINGHOUSE BLVD. SUITE A

    (Street)
    CHARLOTTE NC 28273

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    cbdMD, Inc. [ YCBD ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    05/16/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock(1) 05/16/2025 A 1,572 A $0 12,104 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units vest quarterly on June 30, 2025, September 30, 2025, December 31, 2025 and March 31, 2026. The restricted stock units were issued under the 2021 Equity Compensation Plan as compensation to the Reporting Person for her services on the Issuer's Board of Directors.
    /s/ William Raines III 05/20/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $YCBD alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $YCBD

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $YCBD
    SEC Filings

    See more
    • cbdMD Inc. filed SEC Form 8-K: Other Events

      8-K - cbdMD, Inc. (0001644903) (Filer)

      5/20/25 5:19:59 PM ET
      $YCBD
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form 10-Q filed by cbdMD Inc.

      10-Q - cbdMD, Inc. (0001644903) (Filer)

      5/15/25 4:07:09 PM ET
      $YCBD
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form SCHEDULE 13D filed by cbdMD Inc.

      SCHEDULE 13D - cbdMD, Inc. (0001644903) (Subject)

      5/8/25 4:02:08 PM ET
      $YCBD
      Package Goods/Cosmetics
      Consumer Discretionary

    $YCBD
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $YCBD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Herbal Oasis Expands Footprint with New Distribution Agreement in Georgia

      Charlotte, North Carolina--(Newsfile Corp. - May 21, 2025) - Herbal Oasis ("Oasis"), the hemp-derived THC-infused social seltzer redefining how people connect, unwind, and celebrate life, is proud to announce a new distribution partnership with Beverage South, a leading distributor serving much of the state of Georgia. Starting this month, Oasis will be available on shelves across Georgia as the brand continues its rapid expansion across the Southeast.Georgia marks the fourth state in just two months where Oasis has launched, following successful rollouts in Alabama, Florida, and North Carolina. The partnership with Beverage South significantly strengthens Oasis's presence in one of the regi

      5/21/25 7:00:00 AM ET
      $YCBD
      Package Goods/Cosmetics
      Consumer Discretionary
    • cbdMD Delivers Continued Revenue Growth and Trend Towards Profitability in Second Fiscal Quarter

      Successfully Completes Capital Structure Reset with Series A Preferred ConversionCharlotte, North Carolina--(Newsfile Corp. - May 15, 2025) - cbdMD, Inc. (NYSE:YCBD), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, and Herbal Oasis today announced our financial results for the second quarter of fiscal year ended September 30, 2025. The Company reported continued year-over-year improvements in both revenue and earnings while completing a transformative restructuring of its capital structure.The Company delivered $4.8 million in revenue for the second quarter, up from $4.3 million in the prior year peri

      5/15/25 4:09:00 PM ET
      $YCBD
      Package Goods/Cosmetics
      Consumer Discretionary
    • cbdMD, Inc. to Host Conference Call to Discuss March 31, 2025, Second Quarter of Fiscal Year 2025 Results

      Charlotte, North Carolina--(Newsfile Corp. - May 9, 2025) - cbdMD, Inc. (NYSE:YCBD), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Thursday, May 15, 2025, to discuss the company's March 31, 2025 second quarter of fiscal year 2025 financial results and business progress.CONFERENCE CALL DETAILSThursday, May 15, 2025, 4:20 p.m. Eastern Time USA/Canada:833-821-3524  International:647-846-2919  Teleconference Replay dial in: USA/Canada:855-669-9658  International:412-317-0088  Replay Passcode:7254091  Webcast/Webcast Replay link - available through May 15, 2026: https://www.gowebc

      5/9/25 12:57:00 PM ET
      $YCBD
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form SC 13D/A filed by cbdMD Inc. (Amendment)

      SC 13D/A - cbdMD, Inc. (0001644903) (Subject)

      8/12/22 4:02:14 PM ET
      $YCBD
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form SC 13D/A filed by cbdMD Inc. (Amendment)

      SC 13D/A - cbdMD, Inc. (0001644903) (Subject)

      6/21/22 7:52:33 AM ET
      $YCBD
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form SC 13D/A filed by cbdMD Inc. (Amendment)

      SC 13D/A - cbdMD, Inc. (0001644903) (Subject)

      5/19/22 4:05:28 PM ET
      $YCBD
      Package Goods/Cosmetics
      Consumer Discretionary

    $YCBD
    Leadership Updates

    Live Leadership Updates

    See more
    • cbdMD, Inc. Announces Shareholder Approval of Automatic Conversion of Series A Preferred Stock and Other Results from Annual Meeting

      Charlotte, North Carolina--(Newsfile Corp. - April 10, 2025) - cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBDPA) (the "Company" or "cbdMD") one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its functional mushroom brand ATRx Labs and emerging THC-infused seltzer brand Herbal Oasis announced today that at the Company's annual meeting of shareholders held on April 10, 2025, that its Common Stock holders and 8% Series A Cumulative Convertible Preferred Stock (the "Preferred Stock") holders approved the automatic conversion (the "Conversion") of shares of the Company's Preferred Stock into shares of the Comp

      4/10/25 5:57:00 PM ET
      $YCBD
      Package Goods/Cosmetics
      Consumer Discretionary
    • cbdMD Announces Partnership with Medical Advisor, Dr. Lucille Vega

      Charlotte, North Carolina--(Newsfile Corp. - June 22, 2023) - cbdMD (NYSE:YCBD), one of the nation's leading providers of premium cannabidiol (CBD) products, is delighted to announce the appointment of Dr. Lucille Vega as their new medical advisor. This collaboration marks an exciting chapter for both parties, as they play a pivotal role in educating the public about the numerous benefits of CBD and cbdMD's commitment to quality and transparency.As a brand that's renowned for its commitment to quality and innovation, cbdMD's comprehensive line of products spans across various categories and caters to a diverse range of consumer needs. By partnering with Dr. Vega, a highly qualified and passi

      6/22/23 9:00:00 AM ET
      $YCBD
      Package Goods/Cosmetics
      Consumer Discretionary
    • cbdMD Welcomes Shannon Charles as Chief Marketing Officer

      Charlotte, North Carolina--(Newsfile Corp. - January 11, 2023) - cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBDPA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces the appointment of Shannon Charles as Chief Marketing Officer. Shannon is a veteran in health and wellness with over a decade of success in the Natural Product Industry. She has a proven record in driving growth across B&M retail, warehouse club stores, ecommerce, as well as international markets. Shannon's leadership has supported the successful brand stories of Naturade, NeoCell, and NutraNext, which the latter was ultimately acquired by The Clorox Co during her tenure. "We are thrilled to h

      1/11/23 12:33:00 PM ET
      $YCBD
      Package Goods/Cosmetics
      Consumer Discretionary

    $YCBD
    Financials

    Live finance-specific insights

    See more

    $YCBD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • cbdMD Delivers Continued Revenue Growth and Trend Towards Profitability in Second Fiscal Quarter

      Successfully Completes Capital Structure Reset with Series A Preferred ConversionCharlotte, North Carolina--(Newsfile Corp. - May 15, 2025) - cbdMD, Inc. (NYSE:YCBD), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, and Herbal Oasis today announced our financial results for the second quarter of fiscal year ended September 30, 2025. The Company reported continued year-over-year improvements in both revenue and earnings while completing a transformative restructuring of its capital structure.The Company delivered $4.8 million in revenue for the second quarter, up from $4.3 million in the prior year peri

      5/15/25 4:09:00 PM ET
      $YCBD
      Package Goods/Cosmetics
      Consumer Discretionary
    • cbdMD, Inc. to Host Conference Call to Discuss March 31, 2025, Second Quarter of Fiscal Year 2025 Results

      Charlotte, North Carolina--(Newsfile Corp. - May 9, 2025) - cbdMD, Inc. (NYSE:YCBD), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Thursday, May 15, 2025, to discuss the company's March 31, 2025 second quarter of fiscal year 2025 financial results and business progress.CONFERENCE CALL DETAILSThursday, May 15, 2025, 4:20 p.m. Eastern Time USA/Canada:833-821-3524  International:647-846-2919  Teleconference Replay dial in: USA/Canada:855-669-9658  International:412-317-0088  Replay Passcode:7254091  Webcast/Webcast Replay link - available through May 15, 2026: https://www.gowebc

      5/9/25 12:57:00 PM ET
      $YCBD
      Package Goods/Cosmetics
      Consumer Discretionary
    • cbdMD Generates $5.1 Million in Revenue, Positive Earnings

      Charlotte, North Carolina--(Newsfile Corp. - February 13, 2025) - (NYSE:YCBD) (NYSE:YCBDPA), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its new functional mushroom brand ATRx Labs today announced our financial results for the first quarter of fiscal year ended December 31, 2024. The Company started fiscal 2025 with a historic quarter, achieving sequential revenue growth, positive net income and, although a loss from operations, the first ever quarter of positive non-GAAP Adjusted EBITDA. The Company generated Net Income of $15,000, an approximate $1 million improvement from the prior

      2/13/25 4:10:00 PM ET
      $YCBD
      Package Goods/Cosmetics
      Consumer Discretionary
    • Director Porter Jeffrey H was granted 1,572 shares (SEC Form 4)

      4 - cbdMD, Inc. (0001644903) (Issuer)

      5/20/25 5:23:40 PM ET
      $YCBD
      Package Goods/Cosmetics
      Consumer Discretionary
    • Director Raines William F Iii was granted 1,572 shares, increasing direct ownership by 15% to 12,104 units (SEC Form 4)

      4 - cbdMD, Inc. (0001644903) (Issuer)

      5/20/25 5:23:18 PM ET
      $YCBD
      Package Goods/Cosmetics
      Consumer Discretionary
    • Director Roe Kevin Charles was granted 1,572 shares, increasing direct ownership by 7% to 25,135 units (SEC Form 4)

      4 - cbdMD, Inc. (0001644903) (Issuer)

      5/20/25 5:22:53 PM ET
      $YCBD
      Package Goods/Cosmetics
      Consumer Discretionary

    $YCBD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Cantor Fitzgerald resumed coverage on cbdMD with a new price target

      Cantor Fitzgerald resumed coverage of cbdMD with a rating of Neutral and set a new price target of $3.25 from $4.10 previously

      6/18/21 6:26:36 AM ET
      $YCBD
      Package Goods/Cosmetics
      Consumer Discretionary
    • Cantor Fitzgerald reiterated coverage on cbdMD with a new price target

      Cantor Fitzgerald reiterated coverage of cbdMD with a rating of Neutral and set a new price target of $4.30 from $3.60 previously

      1/29/21 4:54:10 AM ET
      $YCBD
      Package Goods/Cosmetics
      Consumer Discretionary